Carregant...
E3 Ubiquitin Ligase in Anticancer Drugdsla Resistance: Recent Advances and Future Potential
Drug therapy is the primary treatment for patients with advanced cancer. The use of anticancer drugs will inevitably lead to drug resistance, which manifests as tumor recurrence. Overcoming chemoresistance may enable cancer patients to have better therapeutic effects. However, the mechanisms underly...
Guardat en:
| Publicat a: | Front Pharmacol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8082683/ https://ncbi.nlm.nih.gov/pubmed/33935743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.645864 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|